NEW YORK (GenomeWeb) – Empire Genomics said on Monday that it has acquired molecular diagnostic reagents firm ID Labs for an undisclosed amount.

Based in London, Ontario, ID Labs provides antibodies, molecular probes, cytogenetics media, and other molecular biology reagents to academia, government, pharmaceutical, biotech, and hospital customers.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.